Status:
COMPLETED
Betaseron 16-Year Long-Term Follow-Up (LTF) in Patients With Relapsing-Remitting Multiple Sclerosis
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
33+ years
Brief Summary
The purpose of this follow-up study is to look carefully at the long-term course of multiple sclerosis (MS) and possibly the long-term effects of Betaseron in the patients who were previously enrolled...
Detailed Description
This study has previously been posted by Berlex, Inc. Berlex, Inc. has been renamed to Bayer HealthCare Pharmaceuticals, Inc.Bayer HealthCare Pharmaceuticals, Inc. is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Patients in North America have to have been previously enrolled in the original Betaseron trial from 1988-1993
- Be able to understand the consent form (or have a guardian who can)
Exclusion
- North American patients cannot be included if they have not participated in the original Betaseron trial from 1988-1993
Key Trial Info
Start Date :
January 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
432 Patients enrolled
Trial Details
Trial ID
NCT00206635
Start Date
January 1 2005
End Date
December 1 2005
Last Update
November 22 2012
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, Alabama, United States
2
Many Locations, Arizona, United States
3
Many Locations, California, United States
4
Many Locations, Illinois, United States